Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
001065.KS Stock Summary
In the News
001065.KS Financial details
Company Rating
Strong Buy
Market Cap
797.67B
Income
12.13B
Revenue
660.66B
Book val./share
2035.71
Cash/share
-
Dividend
400
Dividend %
1.23%
Employees
1.13K
Optionable
No
Shortable
Yes
Earnings
-
P/E
281.46
Forward P/E
-
PEG
-23.77
P/S
5.17
P/B
15.94
P/C
-
P/FCF
104.58
Quick Ratio
-
Current Ratio
1.22
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
115.29
EPS next Y
-
EPS next Q
-
EPS this Y
-98.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-21.28%
Revenue last 5Y
3.82%
Revenue Q/Q
2.93%
EPS Q/Q
744.09%
-
-
-
-
SMA20
-0.02%
SMA50
-9.17%
SMA100
-10.89%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
6%
ROC
0.16%
Gross Margin
40%
Oper. Margin
7%
Profit Margin
2%
Payout
347%
Shs Outstand
20.1M
Shs Float
11.41M
-
-
-
-
Target Price
-
52W Range
28900.0-39000.0
52W High
-16.79%
52W Low
+12.28%
RSI
46.14
Rel Volume
0.29
Avg Volume
341
Volume
98
Perf Week
-0.92%
Perf Month
-6.75%
Perf Quarter
-11.46%
Perf Half Y
-9.86%
-
-
-
-
Beta
0.333218
-
-
Volatility
390.45%, 1147.31%
Prev Close
0.78%
Price
32450
Change
1.41%
001065.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 20.68K | 22.09K | 21.03K | 22.51K | 5.78K | |
Net income per share | -30.53 | 331.3 | -1.04K | -626.72 | -9.23 | |
Operating cash flow per share | 1.38K | 2.14K | 2.28K | 2.59K | 172.78 | |
Free cash flow per share | 925.17 | 1.8K | 1.74K | 1.97K | 49.79 | |
Cash per share | 1.32K | 1.27K | 1.72K | 2.27K | 625.99 | |
Book value per share | 11.13K | 10.7K | 9.46K | 8.53K | 1.92K | |
Tangible book value per share | 10.31K | 10.07K | 8.58K | 7.8K | 1.59K | |
Share holders equity per share | 11.13K | 10.7K | 9.46K | 8.53K | 1.92K | |
Interest debt per share | 8.19K | 7.56K | 8.17K | 7.8K | 2.41K | |
Market cap | 589.93B | 589.12B | 617.78B | 819.29B | 3514.12B | |
Enterprise value | 748.19B | 733.39B | 763.44B | 991.06B | 3725.89B | |
P/E ratio | -794.55 | 73.12 | -24.44 | -53.75 | -3.63K | |
Price to sales ratio | 1.17 | 1.1 | 1.21 | 1.5 | 5.79 | |
POCF ratio | 17.64 | 11.31 | 11.12 | 12.99 | 193.89 | |
PFCF ratio | 26.22 | 13.46 | 14.56 | 17.06 | 672.89 | |
P/B Ratio | 2.18 | 2.26 | 2.69 | 3.95 | 17.47 | |
PTB ratio | 2.18 | 2.26 | 2.69 | 3.95 | 17.47 | |
EV to sales | 1.49 | 1.37 | 1.49 | 1.81 | 6.14 | |
Enterprise value over EBITDA | 28.43 | 20.04 | -281.95 | 65.61 | 83.81 | |
EV to operating cash flow | 22.37 | 14.07 | 13.75 | 15.72 | 205.58 | |
EV to free cash flow | 33.25 | 16.76 | 17.99 | 20.64 | 713.45 | |
Earnings yield | 0 | 0.01 | -0.04 | -0.02 | 0 | |
Free cash flow yield | 0.04 | 0.07 | 0.07 | 0.06 | 0 | |
Debt to equity | 0.05 | 0.18 | 0.14 | 0.36 | 0.61 | |
Debt to assets | 0.57 | 0.56 | 0.6 | 0.62 | 0.7 | |
Net debt to EBITDA | 6.01 | 3.94 | -53.8 | 11.37 | 4.76 | |
Current ratio | 1.5 | 1.64 | 1.21 | 1.28 | 1.3 | |
Interest coverage | 2.45 | 2.48 | -1.69 | -0.17 | 4.25 | |
Income quality | -45.05 | 6.47 | -2.2 | -4.14 | -18.73 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Payout ratio | -7.93 | 0.81 | -0.27 | -0.46 | -7.39 | |
Sales general and administrative to revenue | 0.12 | 0.12 | 0.08 | 0.12 | 0.14 | |
Research and developement to revenue | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | |
Intangibles to total assets | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.33 | -0.16 | -0.24 | -0.24 | -0.71 | |
Capex to revenue | -0.02 | -0.02 | -0.03 | -0.03 | -0.02 | |
Capex to depreciation | -0.58 | -0.47 | -0.64 | -0.73 | -0.8 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.77K | 8.93K | 14.87K | 10.97K | 631 | |
ROIC | 0.06 | 0.06 | -0.06 | 0 | 0.09 | |
Return on tangible assets | 0 | 0.01 | -0.05 | -0.03 | 0 | |
Graham Net | -11.3K | -10.36K | -10.53K | -9.69K | -3.12K | |
Working capital | 136.83B | 145.54B | 57.07B | 64.58B | 83.77B | |
Tangible asset value | 250.64B | 244.97B | 208.7B | 189.8B | 167.07B | |
Net current asset value | 51.27B | 40.23B | -8.06B | -42.29B | -78.06B | |
Invested capital | 0.7 | 0.67 | 0.82 | 0.88 | 1.22 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 53.74B | 46.17B | 46.49B | 47.89B | 49.76B | |
Average inventory | 103.91B | 101.28B | 95.82B | 101.2B | 101.86B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 69.2 | 47.71 | 46.99 | 47.26 | 50.64 | |
Days of inventory on hand | 123.83 | 108.78 | 94.26 | 99.88 | 100.54 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 5.27 | 7.65 | 7.77 | 7.72 | 7.21 | |
Inventory turnover | 2.95 | 3.36 | 3.87 | 3.65 | 3.63 | |
ROE | 0 | 0.03 | -0.11 | -0.07 | 0 | |
Capex per share | -450.3 | -343.15 | -538.52 | -618.41 | -122.99 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 6.13K | 1.61K | 1.49K | 1.57K | 1.61K | |
Net income per share | 209.32 | -63.93 | 91.09 | 9.34 | 78.8 | |
Operating cash flow per share | 927.64 | 124.58 | 54.89 | 87.58 | 173.43 | |
Free cash flow per share | 794.86 | 84.65 | 18.8 | 66.33 | 140.52 | |
Cash per share | 2.85K | 624.11 | 659.84 | 662.59 | 0 | |
Book value per share | 8.49K | 1.91K | 1.93K | 1.95K | 2.04K | |
Tangible book value per share | 7.73K | 1.59K | 1.62K | 1.63K | 1.91K | |
Share holders equity per share | 8.49K | 1.91K | 1.93K | 1.95K | 2.04K | |
Interest debt per share | 8.86K | 2.36K | 2.42K | 2.34K | 5.39 | |
Market cap | 759.09B | 3577.34B | 3982.43B | 3824.6B | 3530B | |
Enterprise value | 945.61B | 3789.12B | 4201.06B | 4033.7B | 3530B | |
P/E ratio | 37.28 | -132.95 | 103.88 | 973.45 | 106.44 | |
Price to sales ratio | 5.09 | 21.11 | 25.47 | 23.18 | 20.78 | |
POCF ratio | 33.65 | 272.92 | 689.53 | 415.05 | 193.45 | |
PFCF ratio | 39.27 | 401.65 | 2.01K | 548.02 | 238.75 | |
P/B Ratio | 3.68 | 17.78 | 19.58 | 18.66 | 16.48 | |
PTB ratio | 3.68 | 17.78 | 19.58 | 18.66 | 16.48 | |
EV to sales | 6.35 | 22.36 | 26.87 | 24.45 | 20.78 | |
Enterprise value over EBITDA | 74.68 | 243.7 | 235.62 | 296.19 | 289.59 | |
EV to operating cash flow | 41.92 | 289.08 | 727.39 | 437.74 | 193.45 | |
EV to free cash flow | 48.92 | 425.43 | 2.12K | 577.98 | 238.75 | |
Earnings yield | 0.01 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0.03 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.49 | 0.61 | 0.75 | 0.74 | 0 | |
Debt to assets | 0.65 | 0.7 | 0.7 | 0.69 | 0.68 | |
Net debt to EBITDA | 14.73 | 13.62 | 12.26 | 15.35 | 0 | |
Current ratio | 1.43 | 1.3 | 1.46 | 1.52 | 1.22 | |
Interest coverage | 4.57 | 4.43 | 5.64 | 3.39 | 20.39 | |
Income quality | 4.43 | -1.95 | 0.6 | 9.38 | 2.2 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.12 | 0.16 | 0.14 | 0.14 | 0.34 | |
Research and developement to revenue | 0.04 | 0.03 | 0.04 | 0.04 | 0 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0 | |
Capex to operating cash flow | -0.14 | -0.32 | -0.66 | -0.24 | -0.19 | |
Capex to revenue | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | |
Capex to depreciation | -0.81 | -1.04 | -0.81 | -0.56 | -0.85 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.32K | 1.66K | 1.99K | 639.63 | 1.9K | |
ROIC | 0.02 | 0.03 | 0.03 | 0.02 | 0.04 | |
Return on tangible assets | 0.01 | -0.01 | 0.02 | 0 | 0.01 | |
Graham Net | -10.74K | -3.11K | -3.06K | -2.92K | -4.02K | |
Working capital | 105.57B | 83.77B | 117.4B | 124.64B | 74.31B | |
Tangible asset value | 187.89B | 167.07B | 170.23B | 171.8B | 0 | |
Net current asset value | -32B | -78.06B | -74.59B | -68.51B | -7.71B | |
Invested capital | 1.04 | 1.22 | 1.24 | 1.19 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 54.81B | 55.13B | 56.49B | 58.61B | 0 | |
Average inventory | 110.73B | 107.01B | 109.29B | 111.48B | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 48.44 | 44.73 | 53.14 | 52.84 | 0 | |
Days of inventory on hand | 104.45 | 88.8 | 104.7 | 100.51 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 1.86 | 2.01 | 1.69 | 1.7 | 0 | |
Inventory turnover | 0.86 | 1.01 | 0.86 | 0.9 | 0 | |
ROE | 0.02 | -0.03 | 0.05 | 0 | 0.04 | |
Capex per share | -132.77 | -39.93 | -36.09 | -21.25 | -32.91 |
001065.KS Frequently Asked Questions
What is JW Pharmaceutical Corporation stock symbol ?
JW Pharmaceutical Corporation is a KR stock and trading under the symbol 001065.KS
What is JW Pharmaceutical Corporation stock quote today ?
JW Pharmaceutical Corporation stock price is $32450 today.
Is JW Pharmaceutical Corporation stock public?
Yes, JW Pharmaceutical Corporation is a publicly traded company.